Mkts

Adaptive Biotechnologies Corporation

NASDAQ: ADPT
$29.04-0.44 (-1.49%)
As of Nov 13, 9:30 AM ET

Key statistics

Day range
28.3929.78
52-week range
12.0032.21
Today
Open29.69
Previous close29.04
Volume2.06M
Valuation
Market cap4.76B
P/E ratio—
EPS (TTM)-0.41
Income & risk
Dividend / yield—
Beta2.16
Avg volume2.49M
Discussion

ADPT News

Stories mentioning ADPT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue70,87471,68193,97358,87952,44347,45946,43543,190
Cost of Goods Sold18,70818,22418,15717,99916,97918,04516,66719,317
Gross Profit52,16653,45775,81640,88035,46429,41429,76823,873
Operating Expenses
Research & Development23,62321,76323,66924,13424,20323,19224,16325,353
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(19,206)(12,773)10,290(25,036)(29,604)(33,837)(32,632)(47,318)
Interest Income
Interest Expense2,8892,9542,9712,9482,9052,9522,9392,696
Other Expense
Pretax Income
Tax Provision
Net Income (Loss)(20,033)(13,579)9,546(25,614)(29,852)(33,692)(32,071)(46,222)
Earnings Per Share (Basic)(0.13)(0.09)0.06(0.17)(0.20)(0.23)(0.22)(0.31)
Earnings Per Share (Diluted)(0.13)(0.09)0.06(0.17)(0.20)(0.23)(0.22)(0.31)
Weighted Average Shares Outstanding (Basic)155,521151,722152,432152,082149,195147,102147,516147,414
Weighted Average Shares Outstanding (Diluted)155,521151,722163,162152,082149,195147,102147,516147,414

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ADPT

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is a stock listed on the Nasdaq Stock Market under the ticker symbol ADPT. It last traded at $29.04 (Nov 13, 2026, 9:30 AM ET), down 1.5% on the day. That gives Adaptive Biotechnologies a market capitalisation of $4.8B.

Over the past 52 weeks ADPT has traded between $12.00 and $32.21.

Revenue for the quarter ended Mar 31, 2026 was $70.9M; a net loss of $20.0M. Revenue was up 35.1% from $52.4M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$70.9M-$20.0M-28.3%
Dec 31, 2025$71.7M-$13.6M-18.9%
Sep 30, 2025$94.0M$9.5M10.2%
Jun 30, 2025$58.9M-$25.6M-43.5%

From Adaptive Biotechnologies’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…